Diligence memo · auto-generated · as of July 2, 2026
SeeLife Impact 2 LLC
SeeLife Impact 2 LLC looks fair against its niche peers and is active on financing cadence.
Businessfiled
SeeLife Impact 2 LLC operates in Biotechnology, based in DRAPER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
SeeLife Impact 2 LLC has raised $5.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $5.0M on 2025-12-31.
Most recent recorded round closed around 2025-12-31.
Valuation (modeled)modeled
Provath models SeeLife Impact 2 LLC at approximately $13M (range $5.5M–$19M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.81× the median modeled value of Series A Biotechnology companies in 2025–2027 (157 peers) — value vs value, same stage and era. Within the normal band (81% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 6 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 44% of Biotechnology peers (4293 compared).
Modeled value ranks above 22% of those peers.
Closest niche peers: Acasti Pharma Inc., Edesa Biotech, Inc., 4DMedical Ltd, Arialys Therapeutics, Inc., Nuclein, LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.